Does the patient know best? Quality of life assessment in multiple sclerosis trials

Mult Scler. 2014 Feb;20(2):131-2. doi: 10.1177/1352458513513209.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials, Phase III as Topic
  • Dimethyl Fumarate
  • Fumarates / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Quality of Life*
  • Self Report / standards*
  • Surveys and Questionnaires*

Substances

  • Fumarates
  • Immunosuppressive Agents
  • Dimethyl Fumarate